2. Academic Validation
  3. Broadly neutralizing influenza hemagglutinin stem-specific antibody CR8020 targets residues that are prone to escape due to host selection pressure

Broadly neutralizing influenza hemagglutinin stem-specific antibody CR8020 targets residues that are prone to escape due to host selection pressure

  • Cell Host Microbe. 2014 May 14;15(5):644-51. doi: 10.1016/j.chom.2014.04.009.
Kannan Tharakaraman 1,  Vidya Subramanian 1,  David Cain 1,  Viswanathan Sasisekharan 1,  Ram Sasisekharan 2
Affiliations

Affiliations

  • 1 Department of Biological Engineering, Skolkovo-MIT Center for Biomedical Engineering, Koch Institute of Integrative Cancer Research, Infectious Diseases Interdisciplinary Research Group, and Singapore-MIT Alliance for Research and Technology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.
  • 2 Department of Biological Engineering, Skolkovo-MIT Center for Biomedical Engineering, Koch Institute of Integrative Cancer Research, Infectious Diseases Interdisciplinary Research Group, and Singapore-MIT Alliance for Research and Technology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA. Electronic address: rams@mit.edu.
PMID: 24832457 DOI: 10.1016/j.chom.2014.04.009
Abstract

Broadly neutralizing Antibodies (bNAb) that target a conserved region of a viral antigen hold significant therapeutic promise. CR8020 is a bNAb that targets the stem region of influenza A virus (IAV) hemagglutinin (HA). CR8020 is currently being evaluated for prophylactic use against group 2 IAVs in phase II studies. Structural and computational analyses reported here indicate that CR8020 targets HA residues that are prone to antigenic drift and host selection pressure. Critically, CR8020 escape mutation is seen in certain H7N9 viruses from recent outbreaks. Furthermore, the ability of the bNAb Fc region to effectively engage activating Fcγ receptors (FCγR) is essential for antibody efficacy. In this regard, our data indicate that the membrane could sterically hinder the formation of HA-CR8020-FcγRIIa/HA-IgG-FcγRIIIa ternary complexes. Altogether, our analyses suggest that epitope mutability and accessibility to immune complex assembly are important attributes to consider when evaluating bNAb candidates for clinical development.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z